Health Condition 1: O141- Severe pre-eclampsia
Conditions
Interventions
Intervention1: Group D- Dexmedetomidine: With due approval from
institutional ethical committee a
randomised clinical study
will be conducted on severe preeclampsia parturients undergoing caesarean s
Sponsors
JLN Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Parturients with severe preeclampsia undergoing caesarean section under general anaesthesia with asa physical status 1 and 2
Exclusion criteria
Exclusion criteria: 1)ASA status more than 2 2) Mallampati grade more than 2 3) Allergic to study drug 4) Anticipated difficult intubation 5) Requiring more than 2 attempts at intubation 6)BMI 40 or more than 40kg/m2 7) Comorbidities 8) Emergency Caesarean section 9) Consent not given to participate in clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess changes in hemodynamic parameters like heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressureTimepoint: Assessed before nebulization, after completion of nebulization, at the time of laryngoscopy and intubation, at 1 min, 2min, 3min, 4min, 6min, 8min, 10min after intubation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough at time of extubationTimepoint: At the time of extubation;Post operative sore throatTimepoint: At time of extubation, at 6hr post extubation and at 12hr post extubation;Side effects of drugTimepoint: | — |
Countries
India
Contacts
Public ContactDr Arvind Khare
Jawahar lal Nehru Medical College
Outcome results
None listed